We first performed transient siRNA-mediated knockdown of CLDN7 expression in two ovarian cancer cell lines (OVCAR-2 and OVCA420) and tested migration using the Oris cell migration assay. The gene discussed is CLDN7; the disease is ovarian carcinoma.